Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum
Molecular & Cellular Proteomics · 2024
DOI: 10.1016/j.mcpro.2023.100687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024. Verfasst von T Mamie Lih und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: tlih1@jhmi.edu. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancer types, partly because it is frequently identified at an advanced stage, when surgery is no longer feasible. Therefore, early detection using minimally invasive methods such as blood tests may improve outcomes. However, studies to discover molecular signatures for the early detection of PDAC using blood tests have only been marginally successful. In the current study, a quantitative glycoproteomic approach via data-independent acquisition mass spectrometry was utilized to detect glycoproteins in 29 patient-matched PDAC tissues and sera. A total of 892 N-linked glycopeptides originating from 141 glycoproteins had PDAC-associated changes beyond normal variation. We further evaluated the specificity of these serum-detectable glycoproteins by comparing their abundance in 53 independent PDAC patient sera and 65 cancer-free controls. The PDAC tissue-associated glycoproteins we have identified represent an inventory of serum-detectable PDAC-associated glycoproteins as candidate biomarkers that can be potentially used for the detection of PDAC using blood tests.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: tlih1@jhmi.edu.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Pathology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Departments of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics, and School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA; The Sol Goldman Pancreat…
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA; Department of Oncology,…
Förderung
- NIEHS NIH HHS
- NCI NIH HHS
Zitieren
APA
Lih, T. M., Cao, L., Minoo, P., Omenn, G. S., Hruban, R. H., Chan, D. W., Bathe, O. F., & Zhang, H. (2024). Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. Molecular & Cellular Proteomics. https://doi.org/10.1016/j.mcpro.2023.100687
Vancouver
Lih TM, Cao L, Minoo P, Omenn GS, Hruban RH, Chan DW, et al. Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum. Molecular & Cellular Proteomics. 2024. doi:10.1016/j.mcpro.2023.100687
BibTeX
@article{Lih2024,
author = {Lih, T Mamie and Cao, Liwei and Minoo, Parham and Omenn, Gilbert S and Hruban, Ralph H and Chan, Daniel W and Bathe, Oliver F and Zhang, Hui},
title = {Detection of Pancreatic Ductal Adenocarcinoma-Associated Proteins in Serum},
journal = {Molecular & Cellular Proteomics},
year = {2024},
doi = {10.1016/j.mcpro.2023.100687}
}
EUVIMED